Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Non-Current Assets: 2022-2024

Historic Non-Current Assets for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $55.9 million.

  • Immunocore Holdings' Non-Current Assets rose 1.17% to $79.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.7 million, marking a year-over-year increase of 1.17%. This contributed to the annual value of $55.9 million for FY2024, which is 0.90% up from last year.
  • Immunocore Holdings' Non-Current Assets amounted to $55.9 million in FY2024, which was up 0.90% from $55.4 million recorded in FY2023.
  • Immunocore Holdings' Non-Current Assets' 5-year high stood at $55.9 million during FY2024, with a 5-year trough of $52.8 million in FY2022.
  • Its 3-year average for Non-Current Assets is $54.7 million, with a median of $55.4 million in 2023.
  • Data for Immunocore Holdings' Non-Current Assets shows a peak YoY rose of 4.95% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Immunocore Holdings' Non-Current Assets stood at $52.8 million in 2022, then increased by 4.95% to $55.4 million in 2023, then rose by 0.90% to $55.9 million in 2024.